Q4 2022 Holdings
Filed 2023-02-14 | 105 holdings | $168.5M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Dell Technologies Inc(DELL) | CL C | 24703L202 | $14.3M | 355,444 | 8.5% |
| Mastercard Incorporated(MA) | CL A | 57636Q104 | $12.9M | 37,194 | 7.7% |
| Visa Inc(V) | COM CL A | 92826C839 | $8.8M | 42,515 | 5.2% |
| Fiserv Inc(FISV) | COM | 337738108 | $8.7M | 85,926 | 5.2% |
| MSD Acquisition Corp | UNIT 03/25/2026 | G5709C117 | $5.1M | 500,000 | 3.0% |
| Axsome Therapeutics Inc(AXSM) | COM | 05464T104 | $4.3M | 55,124 | 2.5% |
| Coupang Inc(CPNG) | CL A | 22266T109 | $3.8M | 256,264 | 2.2% |
| Paypal Hldgs Inc(PYPL) | COM | 70450Y103 | $3.7M | 52,618 | 2.2% |
| Ishares TR(IWD) | RUS 1000 VAL ETF | 464287598 | $3.6M | 23,825 | 2.1% |
| First Horizon Corporation(FHN) | COM | 320517105 | $3.3M | 135,400 | 2.0% |
| Activision Blizzard Inc(ATVIEUR) | COM | 00507V109 | $3.1M | 40,000 | 1.8% |
| Tegna Inc(TGNA) | COM | 87901J105 | $3.1M | 144,000 | 1.8% |
| Aclaris Therapeutics Inc(ACRS) | COM | 00461U105 | $3.0M | 187,619 | 1.8% |
| Viridian Therapeutics Inc(VRDN) | COM | 92790C104 | $2.9M | 99,982 | 1.7% |
| Vmware Inc(VMWEUR) | CL A COM | 928563402 | $2.9M | 23,600 | 1.7% |
| South Jersey Inds Inc(SJIEUR) | COM | 838518108 | $2.8M | 79,500 | 1.7% |
| Bicycle Therapeutics PLC(BCYC) | SPONSORED ADS | 088786108 | $2.7M | 92,434 | 1.6% |
| Relay Therapeutics Inc(RLAY) | COM | 75943R102 | $2.6M | 176,521 | 1.6% |
| Black Knight Inc(BKIEUR) | COM | 09215C105 | $2.6M | 42,200 | 1.5% |
| Travere Therapeutics Inc(TVTX) | COM | 89422G107 | $2.6M | 121,834 | 1.5% |
| Cymabay Therapeutics Inc(CBAYUSD) | COM | 23257D103 | $2.5M | 395,332 | 1.5% |
| Repare Therapeutics Inc(RPTX) | COM | 760273102 | $2.4M | 164,890 | 1.4% |
| Cogent Biosciences Inc(COGT) | COM | 19240Q201 | $2.1M | 183,984 | 1.3% |
| Prometheus Biosciences Inc | COM | 74349U108 | $2.1M | 19,276 | 1.3% |
| Iveric BIO Inc(OPHTEUR) | COM | 46583P102 | $2.1M | 98,094 | 1.2% |
| Novocure LTD(NVCR) | ORD SHS | G6674U108 | $2.1M | 28,007 | 1.2% |
| Kura Oncology Inc(KURA) | COM | 50127T109 | $2.0M | 164,113 | 1.2% |
| Apellis Pharmaceuticals Inc(APLS) | COM | 03753U106 | $2.0M | 39,111 | 1.2% |
| Catalyst Partnrs Acquisitn C | UNIT 99/99/9999 | G19550113 | $2.0M | 200,000 | 1.2% |
| Verona Pharma PLC(VRNA) | SPONSORED ADS | 925050106 | $1.8M | 68,691 | 1.1% |
| Crinetics Pharmaceuticals in(CRNX) | COM | 22663K107 | $1.7M | 93,893 | 1.0% |
| Edgewise Therapeutics Inc(EWTX) | COM | 28036F105 | $1.7M | 187,480 | 1.0% |
| Arcus Biosciences Inc(RCUS) | COM | 03969F109 | $1.5M | 71,650 | 0.9% |
| Chinook Therapeutics Inc(290A) | COM | 16961L106 | $1.3M | 49,495 | 0.8% |
| Biomea Fusion Inc(BMEA) | COM | 09077A106 | $1.2M | 144,727 | 0.7% |
| Dice Therapeutics Inc | COM | 23345J104 | $1.2M | 39,064 | 0.7% |
| Dyne Therapeutics Inc(DYN) | COM | 26818M108 | $1.2M | 102,431 | 0.7% |
| Celldex Therapeutics Inc New(CLDX) | COM NEW | 15117B202 | $1.1M | 24,742 | 0.7% |
| Ventyx Biosciences Inc(VTYX) | COM | 92332V107 | $1.1M | 33,256 | 0.6% |
| Invesco DB Commdy Indx Trck(DBC) | UNIT | 46138B103 | $1.0M | 42,396 | 0.6% |
| Rhythm Pharmaceuticals Inc(RYTM) | COM | 76243J105 | $1.0M | 35,478 | 0.6% |
| Akero Therapeutics Inc(AKRO) | COM | 00973Y108 | $1.0M | 18,629 | 0.6% |
| Biomarin Pharmaceutical Inc(BMRN) | COM | 09061G101 | $1.0M | 9,701 | 0.6% |
| Sarepta Therapeutics Inc(SRPT) | COM | 803607100 | $999.5K | 7,713 | 0.6% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $999.2K | 25,340 | 0.6% |
| Alnylam Pharmaceuticals Inc(ALNY) | COM | 02043Q107 | $963.9K | 4,056 | 0.6% |
| Amicus Therapeutics Inc(FOLD) | COM | 03152W109 | $944.0K | 77,314 | 0.6% |
| Vaxcyte Inc(PCVX) | COM | 92243G108 | $940.1K | 19,606 | 0.6% |
| Galapagos NV(GLPG) | SPON ADR | 36315X101 | $918.7K | 20,701 | 0.5% |
| Springworks Therapeutics Inc | COM | 85205L107 | $905.2K | 34,803 | 0.5% |